生物活性
TH-302 (Evofosfamide)是选择性靶向实体瘤缺氧激活的前体药物，靶向作用于实体瘤的hypoxic区域，IC50为19 nM，在缺氧条件下比在有氧条件下细胞毒性增强270倍，细胞色素P450代谢稳定。
靶点信息
化学数据
| 目录号 | A11144 |
| M. Wt | 449.0 |
| Formula | C9H16Br2N5O4P |
| Purity | >99% |
| Storage | Store lyophilized at -20ºC, keep desiccated.
In lyophilized form, the chemical is stable for36 months.
In solution, store at -20ºC and use within3 monthsto prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |
| CAS No. | 918633-87-1 |
| Synonyms | TH302 |
| SMILES | CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr |
溶解度
| In vitro (25°C) | DMSO | 80 mg/mL (178.15 mM) |
| Water | Warmed: 9 mg/mL (20.03 mM) |
| Ethanol | 80 mg/mL (178.15 mM) |
| In vivo | 30% propylene glycol, 5% Tween 80, 65% D5W | 28 mg/mL |
*<1 mg/ml means slightly soluble or insoluble.
*Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
储备液配制
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
| 0.1 mM | 22.27 mL | 111.36 mL | 222.72 mL |
| 0.5 mM | 4.45 mL | 22.27 mL | 44.54 mL |
| 1 mM | 2.23 mL | 11.14 mL | 22.27 mL |
| 5 mM | 0.45 mL | 2.23 mL | 4.45 mL |
*The above data is based on the productmolecular weight 449.0 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
